Evidence map›Paper›PMID 41728043›Full record

ArticleAnnals of global health2026

Surveillance of Non-Malignant Asbestos-Related Diseases in an Exposed Population: A Scoping Review.

Camilo de la Pava-Cortés, Esperanza Peña Torres, Tim Driscoll, Catherine Jones, Jennifer Coles, Shane McArdle, Kim Brislane, Matthew Peters, Guillermo Villamizar, Eduardo Algranti and 1 more

Abstract readScoping Review
In one paragraph

Article in Annals of global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Camilo de la Pava-CortésDepartment of Clinical Epidemiology and Public Health, Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.ORCID 0000-0001-7482-6284
Esperanza Peña TorresFacultad de Enfermería, Pontificia Universidad Javeriana, Bogota, Colombia.ORCID 0000-0003-0039-6036
Tim DriscollAsbestos Dust Diseases Research Institute (ADDRI), Sydney School of Public Health, University of Sydney, Australia.ORCID 0000-0003-0057-2490
Catherine JonesAsbestos Dust Diseases Research Institute (ADDRI), University of Sydney, Australia.ORCID 0000-0003-2399-8929
Jennifer ColesAsbestos Dust Diseases Research Institute (ADDRI), Australia.ORCID 0009-0003-0597-0866
Shane McArdleAsbestos Dust Diseases Research Institute (ADDRI), Australia.ORCID 0009-0002-2342-1863
Kim BrislaneAsbestos Dust Diseases Research Institute (ADDRI), Australia.ORCID 0009-0002-4293-1762
Matthew PetersAsbestos Dust Diseases Research Institute (ADDRI) and Faculty of Medicine, Health and Human Sciences, Macquarie University, Australia.ORCID 0000-0002-9649-8741
Guillermo VillamizarFundación Colombia Libre de Asbestos (FUNDCLAS), Bogotá, Colombia.
Eduardo AlgrantiFundação Jorge Duprat Figueiredo de Segurança e Medicina do Trabalho (FUNDACENTRO), São Paulo, Brazil.ORCID 0000-0002-6908-7242
Arthur FrankDrexel University Dornsife School of Public Health, Philadelphia, PA, United States.ORCID 0000-0001-7040-9520

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AsbestosAsbestosisLung NeoplasmsMesotheliomaOccupational ExposurePopulation SurveillanceBrazilColombiaHumansItalyAsbestosepidemiological monitoringoccupational healthpublic health surveillanceregistry systemstoxic exposure

Identifiers

PMID41728043
PMCPMC12922659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.